At the Castello di Rivoli and the GAM, the cutting edge of contemporary art, from Arte Povera to pop art, is celebrated in ...

The Galleria d’Arte Moderna e Contemporanea di Torino (GAM) is hosting the first major Italian retrospective of acclaimed American artist Mary Heilmann. From the three new exhibitions dedicated to ...

Roberto Matta 1911-2002 at Ca’ Pesaro - Galleria Internazionale d’Arte Moderna is the first institutional exhibition in Italy dedicated to the Chilean artist; it aims to portray his eclectic ...

Address: Galleria Civica d’Arte Moderna e Contemporanea, Via Magenta, 31, 10128 Torino Enjoying some modern at Galleria Civica d’Arte Moderna e Contemporanea, Turin Looking for fun things to do in ...

Soy guardia de seguridad aquí en el Museo de Arte Moderno y ahora voy a hablar sobre esta obra ... Durante su creación era como una pieza de danza moderna. También hay gotas de tinta y, como decía ...

Moderna stock has been under pressure amid declining sales of its COVID-19 vaccine. The company projects optimism in its long-term outlook, believing that several pending product approvals can ...

Moderna gains HHS backing for developing mRNA-based pandemic influenza vaccines, advancing clinical studies for up to five subtypes. Get the Real Story Behind Every Major Earnings Report Tuesday ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The biotech, renowned for its pioneering development of vaccines based on ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near ...

Moderna's partnership with Merck in personalized cancer therapies and promising Phase III trials support a speculative 'Buy' for long-term investors with high-risk tolerance. Despite a tough 2024 ...